Advance new therapies. Stay human.

Discover the therapies of tomorrow by catching human data today.

Beating Organs-on-Chip unlock human pre-clinical models reflecting clinical complexity, towards the design of effective treatments tailored for patients.

We present the next generation of preclinical models: human, dynamic, 3D.

Every tissue in the body is subjected to motion. Our Beating Organs-on-Chip finally bring this motion into the 3D native microenvironment offering the next generation of clinically relevant human invitro setups.

Our Services

biologist

Get human relevant data from our  uBeat® models. BiomimX® is the ideal partner to boost your drug discovery&development.

Our Technology

uBeat® ground-breaking technology brings into microscaled setups a unique combination of mechanical stimulation and 3D architecture.

Our Products

BiomimX uBeat platform

uBeat® innovative cell culture setups create the path to develop the next generation of advanced 3D dynamic models.

Meet us

September 18-21, 2023

We are glad to share that BiomimX is going to participate to the Safety Pharmacology Society meeting in Brussels. Click the banner to register!

stay tuned BiomimX

Latest News

🗓 Few days left until the SPS Annual Meeting 2023!
Want to know more about our platforms and their application in cardiotoxicity assessment, don’t miss: 📌 1 Oral Communication by our R&D Product Engineer Caterina Pernici. “Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform” - Caterina Pernici, 1:30 - 1:45 p.m., 19th September, Silver Hall. 📌 2 Poster Presentations by our Business Developer Erika Ferrari and our R&D Product Engineer Caterina Pernici. 🙋‍♀️Meet us at Booth #607, BiomimX’s Team is ready to welcome you!
MPS Educational Workshop
On the occasion of the MPS World Summit, BiomimX is taking part in the Educational Workshops together with other companies operating in the field of Organ-on-Chip (OOC) and Microphysiological systems (MPS). Don’t miss the chance to attend a hands-on demo of commercially available technologies!
Previous slide
Next slide